TP53 and in situ carcinoma: Mutant ras genes induced urothelial hyperplasia at low copy numbers and papillary tumors at high copy numbers, while inactivation of the tumor protein p53 and retinoblastoma (RB1) pathways seem to induce carcinoma in situ (CIS) tumors, able to progress into invasive BCa [6,7].